Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Tayyaba Khan.

Newcastle AuthorsTitleYearFull text
Elizabeth Sconce
Professor Ann Daly
Dr Tayyaba Khan
Dr Hilary Wynne
Professor Farhad Kamali
et al.
APOE genotype makes a small contribution to warfarin dose requirements2006
Elizabeth Sconce
Dr Tayyaba Khan
Professor Ann Daly
Dr Hilary Wynne
Professor Farhad Kamali
et al.
Apolipoprotein E polymorphisms do not make a clinically significant contribution to warfarin dose requirements2006
Dr Hilary Wynne
Dr Tayyaba Khan
Dr Peter Avery
Peter Wood
Professor Farhad Kamali
et al.
Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin2006
Elizabeth Sconce
Dr Tayyaba Khan
Professor Ann Daly
Dr Hilary Wynne
Professor Farhad Kamali
et al.
Simvastatin results in a lower warfarin dose requirement due to a reduced clearance of warfarin2006
Elizabeth Sconce
Dr Tayyaba Khan
Professor Ann Daly
Dr Hilary Wynne
Professor Farhad Kamali
et al.
The impact of simvastatin on warfarin disposition and dose requirements2006
Dr Barry King
Dr Tayyaba Khan
Professor Farhad Kamali
Professor Ann Daly
[abstract] CYP2C9 polymorphisms and haplotypes: correlation with warfarin dose and metabolism2005
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Patrick Kesteven
Dr Peter Avery
et al.
[abstract] Pfizer poster communication prize - The influence of patient age, CYP2C9 genotype and height on warfarin dose requirements2005
Dr Tayyaba Khan
Elizabeth Sconce
Professor Farhad Kamali
Factors contributing to the stability of anticoagulation control and outcome of thromboembolic prophylaxis in the older population2005
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Professor Farhad Kamali
Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation2005
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Professor Farhad Kamali
Patients with unstable control have a poorer dietary intake of vitamin K compared with patients with stable control of anticoagulation2005
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Peter Avery
Dr Barry King
et al.
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen2005
Professor Farhad Kamali
Dr Tayyaba Khan
Dr Barry King
Dr Patrick Kesteven
Peter Wood
et al.
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin2004
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Peter Avery
Dr Patrick Kesteven
Professor Farhad Kamali
et al.
Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin2004
Professor Farhad Kamali
Dr Tayyaba Khan
Dr Barry King
Professor Ann Daly
Dr Hilary Wynne
et al.
The impact of patient age and genetic polymorphism of CYP2C9 on warfarin dose requirements2004
Dr Tayyaba Khan
Professor Farhad Kamali
Dr Patrick Kesteven
Dr Peter Avery
Dr Hilary Wynne
et al.
The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation2004
Dr Barry King
Dr Tayyaba Khan
Professor Farhad Kamali
Professor Ann Daly
Upstream and coding region CYP2C9 polymorphisms: Correlation with warfarin dose and metabolism2004
Dr Barry King
Dr Tayyaba Khan
Professor Farhad Kamali
Professor Ann Daly
Novel CYP2C9 polymorphisms and their relationship to warfarin dose requirements2003